Psyence Group Announces Closing of Fourth Tranche of Private Placement and Conversion of Convertible Debt Note

TORONTO, April 03, 2023 -- Psyence Group inc. , a life science biotechnology company pioneering the use of natural psychedelics in mental health and well-being, is pleased to announce that it has... | April 3, 2023

Related Keywords

Canada ,Toronto ,Ontario ,United Kingdom ,Australia ,United States ,Canadian ,Katherine Murphy ,Canadian Securities Exchange ,Canadian Securities Exchange The ,Psyence Group ,Psyence Group Inc ,Aggregate Proceeds ,Stock Option Plan ,Psyence Production ,Psyence Therapeutics ,Psyence Function ,Southern Africa ,Psyence Group Inc Stock Exchange ,News ,Information ,Press Release ,Pril ,023 ,Psyence ,Group ,Life ,Science ,Biotechnology ,Company ,Ioneering ,The ,Tse ,F ,Natural ,Psychedelics ,N ,Ental ,Health ,End ,Us ,Pleased ,O ,Nnounce ,Hat ,T Psyg Ca74449q1063 ,